164 related articles for article (PubMed ID: 30359624)
1. The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma.
Cumsky HJL; Costello CM; Zhang N; Butterfield R; Buras MR; Schmidt JE; Drenner K; Nelson SA; Ochoa SA; Baum CL; Pittelkow MR; DiCaudo DJ; Sekulic A; Mangold AR
J Am Acad Dermatol; 2019 Mar; 80(3):626-632.e1. PubMed ID: 30359624
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.
Maly CJ; Cumsky HJL; Costello CM; Schmidt JE; Butterfield RJ; Zhang N; DiCaudo DJ; Nelson SA; Smith ML; Ochoa SA; Baum CL; Nagel TH; Pittelkow MR; Sekulic A; Mangold AR
J Am Acad Dermatol; 2020 Apr; 82(4):846-853. PubMed ID: 31437542
[TBL] [Abstract][Full Text] [Related]
3. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.
Chen A; Santana AL; Doudican N; Roudiani N; Laursen K; Therrien JP; Lee J; Felsen D; Carucci JA
PLoS One; 2020; 15(11):e0241551. PubMed ID: 33227008
[TBL] [Abstract][Full Text] [Related]
4. Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous cell carcinoma.
Sekulic A; Kim SY; Hostetter G; Savage S; Einspahr JG; Prasad A; Sagerman P; Curiel-Lewandrowski C; Krouse R; Bowden GT; Warneke J; Alberts DS; Pittelkow MR; DiCaudo D; Nickoloff BJ; Trent JM; Bittner M
Cancer Prev Res (Phila); 2010 Oct; 3(10):1277-83. PubMed ID: 20876729
[TBL] [Abstract][Full Text] [Related]
5. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
6. A new gene panel as a marker for ESCC poor prognosis; INPP5A, TWIST1, MMP2, and EGFR.
Fardi Golyan F; Forghanifard MM
Adv Med Sci; 2021 Sep; 66(2):231-236. PubMed ID: 33798953
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
8. INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma.
Ardalan Khales S; Aarabi A; Abbaszadegan MR; Forghanifard MM
Iran Biomed J; 2022 Nov; 26(6):440-53. PubMed ID: 36437782
[TBL] [Abstract][Full Text] [Related]
9. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
10. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
11. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
12. Tumor Budding Is an Objective High-risk Factor Associated With Metastasis and Poor Clinical Prognosis in Cutaneous Squamous Cell Carcinoma Sized <4 cm.
Fujimoto M; Yamamoto Y; Takai T; Fujimoto N; Ogawa K; Yoshikawa T; Matsuzaki I; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
Am J Surg Pathol; 2019 Jul; 43(7):975-983. PubMed ID: 31094931
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
[TBL] [Abstract][Full Text] [Related]
14. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.
Carter JB; Johnson MM; Chua TL; Karia PS; Schmults CD
JAMA Dermatol; 2013 Jan; 149(1):35-41. PubMed ID: 23324754
[TBL] [Abstract][Full Text] [Related]
17. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
[TBL] [Abstract][Full Text] [Related]
18. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study.
Ross AS; Whalen FM; Elenitsas R; Xu X; Troxel AB; Schmults CD
Dermatol Surg; 2009 Dec; 35(12):1859-66. PubMed ID: 19889009
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].
Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP
An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
